Rola i zadania AOTMiT

Autor: Topór-Mądry, Roman, Dziurda, Dominik R., Kordecka, Anna, Malinowska, Kamila, Parkitna, Joanna, Tatara, Tomasz, Włodarczyk, Agnieszka

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3647::c38516e15fec34c7222b78d39028de5f
https://ruj.uj.edu.pl/xmlui/handle/item/274109

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: Findings and future implications

Autor: Godman, Brian, Wettermark, Björn, van Woerkom, Menno, Fraeyman, Jessica, Alvarez-Madrazo, Samantha, Berg, Christian Lie, Bishop, Iain, Bucsics, Anna, Campbell, Stephen, Finlayson, Alexander E., Fürst, Jurij, Garuoliene, Kristina, Herholz, Harald, Kalaba, Marija, Laius, Ott, Piessnegger, Jutta, Sermet, Catherine, Schwabe, Ulrich, Vlahovic-Palcevski, Vera V., Markovic-Pekovic, Vanda, Vončina, Luka, Malinowska, Kamila, Zara, Corinne, Gustafsson, Lars L.

Externí odkaz: http://hdl.handle.net/11250/279007

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Autor: Godman B; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge Stockholm, Sweden ; Medicines Use and Health, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow, UK ; Liverpool Health Economics Centre, University of Liverpool Management School Liverpool, UK., Wettermark B; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge Stockholm, Sweden ; Centre for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital Solna, Stockholm, Sweden ; Department of Healthcare Development, Public Healthcare Services Committee, Stockholm County Council Stockholm, Sweden., van Woerkom M; Dutch Institute for Rational Use of Medicines Utrecht, Netherlands., Fraeyman J; Epidemiology and Social Medicine, Research Group Medical Sociology and Health Policy, University of Antwerp Antwerp, Belgium., Alvarez-Madrazo S; Medicines Use and Health, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow, UK., Berg C; Division of Epidemiology, Department of Pharmacoepidemiology, Norwegian Institute of Public Health Oslo, Norway., Bishop I; Public Health and Intelligence Business Unit, National Services NHS Scotland Edinburgh, UK., Bucsics A; Department of Finance, Faculty of Business, Economics and Statistics, University of Vienna Vienna, Austria ; Department of Reimbursement, Hauptverband der Österreichischen Sozialversicherungsträger Vienna, Austria., Campbell S; Centre for Primary Care, Institute of Population Health, University of Manchester Manchester, UK., Finlayson AE; Green Templeton College, University of Oxford Oxford, UK., Fürst J; Health Insurance Institute Ljubljana, Slovenia., Garuoliene K; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, University of Vilnius Vilnius, Lithuania ; Medicines Reimbursement Department, National Health Insurance Fund Vilnius, Lithuania., Herholz H; Kasemarzliche Vereinigung Hessen Frankfurt am Main, Germany., Kalaba M; Department of Medicines and Pharmacoeconomics, Republic Fund for Health Insurance Belgrade, Serbia., Laius O; State Agency of Medicines Tartu, Estonia., Piessnegger J; Department of Reimbursement, Hauptverband der Österreichischen Sozialversicherungsträger Vienna, Austria., Sermet C; IRDES Paris, France., Schwabe U; Institute of Pharmacology, University of Heidelberg Heidelberg, Germany., Vlahović-Palčevski VV; Department of Clinical Pharmacology, University Hospital Rijeka Rijeka, Croatia., Markovic-Pekovic V; Faculty of Medicine, University of Banja Luka Banja Luka, Republic Srpska, Bosnia and Herzegovina ; Ministry of Health and Social Welfare Banja Luka, Republic Srpska, Bosnia and Herzegovina., Vončina L; Ministry of Health Republic of Croatia, Zagreb, Croatia., Malinowska K; Department of Epidemiology and Health Promotion, Public Health School Warsaw, Poland ; Drug Management Department, National Health Fund Warsaw, Poland., Zara C; Barcelona Health Region, Catalan Health Service Barcelona, Spain., Gustafsson LL; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge Stockholm, Sweden.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2014 Jun 17; Vol. 5, pp. 106. Date of Electronic Publication: 2014 Jun 17 (Print Publication: 2014).